These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9676284)

  • 1. Therapy for patients with heparin-induced thrombocytopenia marketed.
    Am J Health Syst Pharm; 1998 Jul; 55(14):1444. PubMed ID: 9676284
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 3. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia with thromboembolic arterial occlusion treated with recombinant hirudin.
    Schmidt OH; Lang W
    N Engl J Med; 1997 Nov; 337(19):1389. PubMed ID: 9380091
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract]   [Full Text] [Related]  

  • 6. [Refludan: pharmacologic surveillance study].
    Winicki J
    Presse Med; 1998 Jun; 27 Suppl 2():31-2. PubMed ID: 9765664
    [No Abstract]   [Full Text] [Related]  

  • 7. Image of the month. Heparin-induced thrombocytopenia: stop all heparin therapy and treat with lepirudin.
    Bush RL; Lin PH; Lumsden AB
    Arch Surg; 2002 Feb; 137(2):221-2. PubMed ID: 11822964
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticoagulation after venous thrombosis caused by type-II HIT syndrome].
    Janssens U
    Dtsch Med Wochenschr; 1998 Apr; 123(14):438-9. PubMed ID: 9581173
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heparin-induced thrombocytopenia type II].
    Breuer HW; Müller R; Greinacher A
    Dtsch Med Wochenschr; 1999 Jan; 124(3):67. PubMed ID: 9987492
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia.
    Tong LM; Mendez MN
    Prog Cardiovasc Nurs; 2002; 17(3):142-7. PubMed ID: 12091763
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of heparin induced thrombocytopenia and thrombosis during the first trimester of pregnancy.
    Mehta R; Golichowski A
    J Thromb Haemost; 2004 Sep; 2(9):1665-6. PubMed ID: 15333046
    [No Abstract]   [Full Text] [Related]  

  • 12. Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia.
    Reilly MP; Weiss R; Askenase A; Tuite C; Soulen M; Mohler ER
    Vasc Med; 2000; 5(4):239-42. PubMed ID: 11213236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant hirudin in clinical practice: focus on lepirudin.
    Greinacher A; Lubenow N
    Circulation; 2001 Mar; 103(10):1479-84. PubMed ID: 11245656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure--a case report.
    Whelen S; Carr ME
    Angiology; 2001 Oct; 52(10):711-5. PubMed ID: 11666136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 16. HIT, HITT, and desulfatohirudin: look before you leap.
    Edmunds LH
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):1-3. PubMed ID: 7609532
    [No Abstract]   [Full Text] [Related]  

  • 17. Re-exposure to recombinant (r)-hirudin in antihirudin antibody-positive patients with a history of heparin-induced thrombocytopenia.
    Harenberg J; Huhle G; Wang LC; Hoffmann U; Song XH
    Br J Haematol; 2000 May; 109(2):360-3. PubMed ID: 10848825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia: pathophysiology and management.
    Mureebe L; Silver D
    Vasc Endovascular Surg; 2002; 36(3):163-70. PubMed ID: 12075381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bivalirudine in heparin-induced thrombocytopenia].
    Gasol-Boncompte M; Gracia-García B; Pastó-Cardona L; Jódar-Masanes R
    Farm Hosp; 2009; 33(5):285-6. PubMed ID: 19775579
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of recombinant hirudin in patients with heparin-induced thrombocytopenia with thrombosis requiring cardiopulmonary bypass.
    Latham P; Revelis AF; Joshi GP; DiMaio JM; Jessen ME
    Anesthesiology; 2000 Jan; 92(1):263-6. PubMed ID: 10638925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.